Austin Top 50
Author:
Equillium, Inc.
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event
April 20, 2026
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
April 8, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 2, 2026
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
March 25, 2026
Equillium to Participate in the 38th Annual Roth Conference
March 18, 2026
FinVolution Group Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
March 17, 2026
Equillium Announces $35 Million Financing with RA Capital Management
March 13, 2026